🇸🇬

Singapore

Asia Pacific

Singapore has positioned itself as Asia's biotech gateway with the Biopolis research hub. Strong government incentives and a favorable regulatory environment attract multinational R&D centers.

Biotech Market Cap
$2.3B
Public Companies
2
Total Companies
2
30D Performance
-8.17%

BIOTECH MARKET CAP INDEX

$2.3B-22.1%ALL

BIOTECH HUBS

BiopolisTuas

COMPANIES

#CompanyValuation
1
WaVe Life Sciences
WaVe Life SciencesWVE
$2.3B
2
CytoMed Therapeutics
CytoMed TherapeuticsGDTC
$11.9M